During the past decade, University of California conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California" #1 sponsor was "Astellas Pharma Global Development, Inc." with 2 trials, followed by "ViiV Healthcare" with 2 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Cheetah Medical Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of California" are "Advanced Solid Tumors" (1 trials), "Atrial Fibrillation" (1 trials), "Bladder Cancer" (1 trials), "Distal Femur Fracture" (1 trials) and "HIV Coinfection" (1 trials). Many other conditions were trialed in "University of California" in a lesser frequency.

Most popular intervention types in "University of California" are "Drug" (6 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ASP1951" (1 trials), "Dabigatran Etexilate 150mg" (1 trials), "Distal femur plates" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California" are 8 trials for "All" genders.

Currently, there are NaN active trials in "University of California". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of California, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".